Share Name Share Symbol Market Type Share ISIN Share Description
Crossword Cybersecurity Plc LSE:CCS London Ordinary Share GB00BPFJXS57 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 460.00p 440.00p 480.00p 460.00p 460.00p 460.00p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services - - - - 22

Crossword Cybersecurity Share Discussion Threads

Showing 1 to 10 of 325 messages
Chat Pages: Latest  1
I know the company and have bought shares, these are worth a look
Clarity Commerce Solutions Plc (EPIC: CCS) have just e-mailed their first interim results for the period ended September 30. Here are the highlights: * TURNOVER: £1,448,000. * GROSS PROFIT: £623,000. * CASH BALANCES: £733,000. * MAJOR CONTRACTS WITH PUNCH GROUP AND P & O. * LAUNCH OF NEW WEB-BASED FRONT END PRODUCTS. * SIGNIFICANT NEW SALES PROSPECTS. Current trading and prospects: "The company is currently trading in line with expectations, with a rapidly-growing pipeline of sales prospects. We will continue to grow organically and by complementary acquisitions in the hospitality and leisure markets, and the board looks forward to the future with confidence," says chairman A.L.R. Morton.
derek wild
Last chance to buy, this ones going to fly CCS @ £1.37
I saw this company (Clarity Commerce Solutions) at a trade exhibition, they have some very good clients, interesting new software and cash in the bank. A small company and the shares are tightly held which means they may move quickly on any news. Also as a newly floated stock they will be eager to impress. Good prospects here for growth hunters IMHO
Probably wise, I wouldn't buy in from scratch at the moment, I'm only staying because the value of my holding has become so small it's not worth selling, if the price continues to drift back I won't bother with the rights either. Maybe just maybe one day.
It is hard to get excited about this company. The name change is warranted. It has been stabilised and probably "saved" but what high value products does it have in the pipeline? Several potentials but they have all been put back into early stage clinical and pre-clinical trials. This company has a long way to go to deliver therapeutic products. It seems as those which it has, will be licenced out in early stages and hence at much lower fees and royalties than if they are developed through by the company. The SmithKline deal for otitis media and the statements by management, indicates this. Now that it appears that most (nobby says all) of its scientific staff have gone, will it become a kind of mini BTG. Picking up the right to develop research that has been done at just a few universities and then contracting out development? However, without saying which university liaisons it has dropped and which it has kept, Cortecs/Provalis has said that it has scaled back those arrangements. Nor can I see it getting any more research grants from Australia. Better to put your money into BTG if you ask me. So, where is its pipeline going to be fed from? What sort of smart brains does it have left. I thought that was supposed to be the main resource in a biotech. I am selling my remaining parcel of shares. Had kept a few to see if Macrulin would generate any excitement. This is still in pre-clinical/Phase I after being put back from Phase II (conservative treatment again) and I can use my money better elsewhere. Plenty of time to come back in during Phase II/III by which time the performance of the company can be better assessed. It seems to me that this company is going to be played conservatively and will get low returns. If I want to be invested in a healthcare/diagnostics company, I can find better prospects elsewhere. I also find it hard to value the company at present. Does anyone have recent figures from a broker?
Rd-racer >>Lets just say, its hard for it to be worse... so that probably means you should feel better.... maybe. NickB >> Thanks. BTW, We had to change the name from Edge to 2C so we could TM it. :)
Is it supposed to make me feel better or worse, worse I suspect.
This is the ultimate faller!! It tops the relative weekness charts for 12 months, 3 months and 1 month a while back. Wouldnt it be nice to buy a few, just so you can brag if it doubles! :) Heres a little model. Distance from the sun 3 month relative weekness. Anticlockwise position 1 year relative weakness, size 1 month relative weekness. (This data was taken a couple of months back). Includes all UK fallers that have experienced relative weakness over 1 year, 3 months and 1 month. Impressive huh. (By the way that is a log spiral you're looking at.)
Apologies for the formating on the pasted bit, its gone to pot during the post.
Chat Pages: Latest  1
Your Recent History
Crossword ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191017 12:38:18